Status:
UNKNOWN
Pilot-Study for SAS Treatment in Acute Cerebral InfarctiOn: the PISTACIO Trial
Lead Sponsor:
SOS Attaque Cérébrale
Conditions:
Ischemic Stroke
Sleep Apnea Syndromes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sleep Apnea Syndrome (SAS) is highly prevalent in acute stroke and it is related to worst outcome. We aim to assess if SAS treatment, started immediately after acute ischemic stroke, impacts infarct g...
Eligibility Criteria
Inclusion
- acute ischemic stroke on brain MRI
- NIHSS 6-22
- thrombolysis
Exclusion
- Previous SAS
- Previous stroke
- Auto-adaptative Servo-Ventilation Contraindication
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04801069
Start Date
March 15 2021
End Date
September 15 2023
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meseguer
Paris, France, 75018